findmyKOL
Clinical trialNCT00050921CompletedInterventional

Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment60HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is designed to evaluate the ability of growth hormone (GH, also known as somatropin) to increase CD4+ cell counts in patients taking anti-HIV drugs. The study is targeted toward patients with low levels of HIV who continue to have low CD4+ cell counts.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Alabama Therapeutics Crs

    Birmingham, Alabama, United States

  • Ucla Care Center Crs

    Los Angeles, California, United States

  • Uc Davis Medical Center

    Sacramento, California, United States

  • Univ. of California Davis Med. Ctr., Actu

    Sacramento, California, United States

  • Ucsf Aids Crs

    San Francisco, California, United States

  • University of Colorado Hospital Crs

    Aurora, Colorado, United States

  • Northwestern University Crs

    Chicago, Illinois, United States

  • Rush Univ. Med. Ctr. Actg Crs

    Chicago, Illinois, United States

  • Univ. of Iowa Healthcare, Div. of Infectious Diseases

    Iowa City, Iowa, United States

  • Beth Israel Med. Ctr., Actu

    New York, New York, United States

  • Case Crs

    Cleveland, Ohio, United States

  • Metrohealth Crs

    Cleveland, Ohio, United States

  • Univ. of Texas Southwestern Med. Ctr., Amelia Court Continuity Clinic

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Hepatitis A virusKeyhole limpet hemocyaninSomatropin →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
—
Primary completion
—
Completion
31 Mar 2005
Last update posted
1 Nov 2021
Registered enrollment
60
Registry id
NCT00050921
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.